Rapaport Elliot .1979 .Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation, 59(3) : 607-9.
Abdelaziz A,Elsayed H,Atta K,Mechi A,Kadhim H,Aboutaleb AM,Elaraby A,Ellabban MH,Eid M,AboElfarh HE,Ibrahim RA,Zawaneh EA,Ezzat M,Abdelaziz M,Hafez A,Mahmoud A,Ghaith HS,Suppah M .2024 .A comprehensive guide on the optimal timing of PCI in the setting of acute coronary syndrome: An updated meta-analysis. Int. J. Cardiol., 400 : 131774.
Bramsved R,Bygdell M,Martikainen J,Mårild S,Lindh I,Rosengren A,Ohlsson C,Kindblom JM C .2024 .Birth weight, childhood and young adult overweight, and the risk of coronary heart disease in men. Arterioscler Thromb Vasc Biol, 44(1) : 314-321.
Cao J,Zhang L,Ma L,Zhou X,Yang B,Wang W .2022 .Study on the risk of coronary heart disease in middle-aged and young people based on machine learning methods: A retrospective cohort study. Peer J., 10 : e14078.
Dugunchi F,Mudgal SK,Marznaki ZH,Shirafkan H,Abrotan S,Jafarian F,Pourkia R F .2024 .Levels of adherence to treatment, illness perception and acceptance of illness in patients with coronary artery disease - descriptive and correlational study. BMC Cardiovasc Disord., 24(1) : 171.
Ekman I,Andersson G,Boman K,Charlesworth A,Cleland JG.,Poole-Wilson P,Swedberg K P .2006 .Adherence and perception of medication in patients with chronic heart failure during a five-year randomised trial. Patient Educ Couns., 61(3) : 348-53.
Gast A and T Mathes .2019 .Medication adherence influencing factors-an (updated) overview of systematic reviews. Syst. Rev., 8(1) : 112.
Guo A,Jin H,Mao J,Zhu W,Zhou Y,Ge X,Yu D X .2023 .Impact of health literacy and social support on medication adherence in patients with hypertension: A cross-sectional community-based study. BMC Cardiovasc Disord., 23(1) : 93.
Hao JY,Zhang J,Jing R,Liu JJ,Di CY,Lu YJ,Gao P,Wang YJ,Yang RF,Lin WH .2021 .Clinical prognosis of optimal medical therapy after percutaneous coronary intervention in patients with coronary heart disease. Chin. Med. J. (Engl)., 134(16) : 2003-2005.
Iranpour A,Sarmadi V,Alian Mofrad A,Mousavinezhad SA,Mousavinezhad SM,Mohammad Alizadeh F and Neshat S SM .2022 .The Persian version of the 8-item Morisky Medication Adherence Scale (MMAS-8): Can we trust it. , 21(1) : 835-840.
Kirov H,Caldonazo T,Rahouma M,Robinson NB,Demetres M,Serruys PW,Biondi-Zoccai G,Gaudino M,Doenst T .2022 .A systematic review and metaanalysis of percutaneous coronary intervention compared to coronary artery bypass grafting in non-STelevation acute coronary syndrome. Sci. Rep, 12(1) : 5138.
Krueger K,Botermann L,Schorr SG,Griese-Mammen N,Laufs U,Schulz M U .2015 .Age-related medication adherence in patients with chronic heart failure: A systematic literature review. Int. J. Cardiol., 184 : 728-735.
Kulkarni SP,Alexander KP,Lytle B,Heiss G .2006 .). Long-term adherence with cardiovascular drug regimens. Am. Heart J., 151(1) : 185-91.
Kvarnström K,Westerholm A,Airaksinen M,Liira H M .2021 .Factors contributing to medication adherence in patients with a chronic condition: A scoping review of qualitative research. , 13(7) : 1100.
Marselin A,Amalia L,Dinarti LK .2023 .The interventions to improve medication adherence in coronary heart disease patient: A systematic review. J. Saudi Heart Assoc., 35(4) : 259-278.
Mondesir FL,Levitan EB,Malla G,Mukerji R,Carson AP,Safford MM,Turan JM .2019 .Patient Perspectives on Factors Influencing Medication Adherence Among People with Coronary Heart Disease (CHD) and CHD Risk Factors. Patient Prefer Adherence, 13 : 2017-2027.
Ni Z,Dardas L,Wu B,Shaw R B .2019 .Cardioprotective medication adherence among patients with coronary heart disease in China: A systematic review. Heart Asia, 11(2) : e011173.
Passacquale G,Sharma P,Perera D,Ferro A .2022 .Antiplatelet therapy in cardiovascular disease: Current status and future directions. Br. J. Clin. Pharmacol, 88(6) : 2686-2699.
Pelliccia F,Zimarino M,Niccoli G,Morrone D,De Luca G,Miraldi F and De Caterina R G .2023 .In-stent restenosis after percutaneous coronary intervention: Emerging knowledge on biological pathways. Eur. Heart J. Open, 3(5) : oead083.
Peng KG,HL Yu KG .2021 .Characteristic analysis of clinical coronary heart disease and coronary artery disease concerning young and middle-aged male patients. World J. Clin. Cases, 9(25) : 7358-7364.
Qian X,Deng H,Yuan J,Hu J,Dai L,Jiang T .2022 .Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: A systematic review and meta-analysis. J. Thorac. Dis., 14(4) : 1183-1192.
Redfern J,Gallagher R,Maiorana A,Candelaria D,Hollings M,Gauci S,O'Neil A,Chaseling GK,Zhang L,Thomas EE,Ghisi GLM,Gibson I,Hyun K,Beatty A,Briffa T,Taylor RS,Arena R,Jennings C,Wood D,Grace SL .2024 .Cardiac rehabilitation and secondary prevention of CVD: Time to think about cardiovascular health rather than rehabilitation. NPJ Cardiovasc. Health, 1(1) : 22.
Shahin W,I. Stupans W .2021 .The association between social support and medication adherence in patients with hypertension: A systematic review. Pharm. Pract, 19(2) : 2300.
Shan Y,Chen J,Zhou S,Wen G .2023 .Nursing Interventions and care strategies for patients with coronary heart disease: A comprehensive review. Galen Med, 12 : 1-13.
Shen B,Guan T,Du X,Pei C,Zhao J,Liu Y .2022 .Medication Adherence and Perceived Social Support of Hypertensive Patients in China: A Community-Based Survey Study. Patient Prefer Adherence, 16 : 1257-1268.
Sigamani A and R Gupta .2022 .Revisiting secondary prevention in coronary heart disease. Indian Heart J, 74(6) : 431-440.
Studer CM,Linder M,Pazzagli L .2023 .A global systematic overview of socioeconomic factors associated with antidiabetic medication adherence in individuals with type 2 diabetes. J. Health Popul. Nutr, 42(1) : 122.
Tan MC,Dinh D,Gayed D,Liang D,Brennan A,Duffy SJ,Clark D,Ajani A,Oqueli E,Roberts L,Reid C,Freeman M,Chandrasekhar J .2024 .Associations between dual antiplatelet therapy score and long-term mortality after percutaneous coronary intervention: analysis of more than 27,000 patients. , 40(11) : 2045-2053.
Wilder ME,Kulie P,Jensen C,Levett P,Blanchard J,Dominguez LW,Portela M,Srivastava A,Li Y,McCarthy ML Y .2021 .The impact of social determinants of health on medication adherence: A systematic review and meta-analysis. J. Gen. Intern. Med, 36(5) : 1359-1370.
Xiang Q,Xiong XY,Liu S,Zhang MJ,Li YJ,Wang HW,Wu R,Chen L R .2024 .Risk prediction model for instent restenosis following PCI: A systematic review. Front. Cardiovasc. Med, 11 : 1445076.
Yin S,Ou Y,Ting E .2022 .Impacts of Omaha system-based continuing care on the medication compliance, quality of life, and prognosis of coronary heart disease patients after PCI. Braz. J. Cardiovasc. Surg., 37(4) : 472-480.
Yu M,Wang L,Guan L,Qian M,Lv J,Deng M .2022 .Knowledge, attitudes, and barriers related to medication adherence of older patients with coronary heart disease in China. , 43 : 235-241.
Yusuf S,Islam S,Chow CK,Rangarajan S,Dagenais G,Diaz R,Gupta R,Kelishadi R,Iqbal R,Avezum A,Kruger A,Kutty R,Lanas F,Lisheng L,Wei L,LopezJaramillo P,Oguz A,Rahman O,Swidan H,Yusoff K H .2011 .Use of secondary prevention drugs for cardiovascular disease in the community in highincome, middle-income, and low-income countries (the PURE Study): A prospective epidemiological survey. Lancet., 378(9798) : 1231-43.
Zhao S,Zhao H,Wang L,Du S,Qin Y .2015 .Education is critical for medication adherence in patients with coronary heart disease. Acta Cardiol., 70(2) : 197-204.
Zhu Y,Zhao Y,Wu Y .2024 .Effectiveness of mobile health applications on clinical outcomes and health behaviors in patients with coronary heart disease: A systematic review and meta-analysis. Int. J. Nurs. Sci., 11(2) : 258-275.